Statins for Renal Patients: A Fiddler on the Roof?
Atherosclerotic cardiovascular disease is the main cause of morbidity and mortality in chronic kidney disease patients. There is a raft of evidence showing that in the general population dyslipidaemia is associated with an increased risk of cardiovascular events, as well as with a greater prevalence...
Saved in:
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | International Journal of Nephrology |
Online Access: | http://dx.doi.org/10.1155/2012/806872 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832556978917867520 |
---|---|
author | Anabela Malho Guedes Pedro Leão Neves |
author_facet | Anabela Malho Guedes Pedro Leão Neves |
author_sort | Anabela Malho Guedes |
collection | DOAJ |
description | Atherosclerotic cardiovascular disease is the main cause of morbidity and mortality in chronic kidney disease patients. There is a raft of evidence showing that in the general population dyslipidaemia is associated with an increased risk of cardiovascular events, as well as with a greater prevalence of chronic kidney disease. Consequently, the use of statins in the general population with dyslipidaemia is not controversial. Nevertheless, the benefits of statins in patients with chronic kidney disease are more elusive. The authors review the possible effects of statins on the progression of renal disease and cardiovascular events in chronic kidney disease patients. |
format | Article |
id | doaj-art-c2bbcafe54c74b9ba4c9b57b62758d0a |
institution | Kabale University |
issn | 2090-214X 2090-2158 |
language | English |
publishDate | 2012-01-01 |
publisher | Wiley |
record_format | Article |
series | International Journal of Nephrology |
spelling | doaj-art-c2bbcafe54c74b9ba4c9b57b62758d0a2025-02-03T05:43:54ZengWileyInternational Journal of Nephrology2090-214X2090-21582012-01-01201210.1155/2012/806872806872Statins for Renal Patients: A Fiddler on the Roof?Anabela Malho Guedes0Pedro Leão Neves1Serviço de Nefrologia, Hospital de Faro, 8000 Faro, PortugalServiço de Nefrologia, Hospital de Faro, 8000 Faro, PortugalAtherosclerotic cardiovascular disease is the main cause of morbidity and mortality in chronic kidney disease patients. There is a raft of evidence showing that in the general population dyslipidaemia is associated with an increased risk of cardiovascular events, as well as with a greater prevalence of chronic kidney disease. Consequently, the use of statins in the general population with dyslipidaemia is not controversial. Nevertheless, the benefits of statins in patients with chronic kidney disease are more elusive. The authors review the possible effects of statins on the progression of renal disease and cardiovascular events in chronic kidney disease patients.http://dx.doi.org/10.1155/2012/806872 |
spellingShingle | Anabela Malho Guedes Pedro Leão Neves Statins for Renal Patients: A Fiddler on the Roof? International Journal of Nephrology |
title | Statins for Renal Patients: A Fiddler on the Roof? |
title_full | Statins for Renal Patients: A Fiddler on the Roof? |
title_fullStr | Statins for Renal Patients: A Fiddler on the Roof? |
title_full_unstemmed | Statins for Renal Patients: A Fiddler on the Roof? |
title_short | Statins for Renal Patients: A Fiddler on the Roof? |
title_sort | statins for renal patients a fiddler on the roof |
url | http://dx.doi.org/10.1155/2012/806872 |
work_keys_str_mv | AT anabelamalhoguedes statinsforrenalpatientsafiddlerontheroof AT pedroleaoneves statinsforrenalpatientsafiddlerontheroof |